Related Experiment Videos

Identifying genes that regulate bone remodeling as potential therapeutic targets

Stephen M Krane1

  • 1Harvard Medical School and Massachusetts General Hospital, Boston, MA 02129, USA. krane.stephen@mgh.harvard.edu

The Journal of Experimental Medicine
|March 23, 2005
PubMed

Insights

Ciz inhibits osteoblast differentiation by interfering with bone morphogenic protein signaling. Ciz-deficient mice exhibit increased bone mass, suggesting Ciz as a therapeutic target for bone loss conditions like osteoporosis.

Area of Science:

  • Bone biology and skeletal diseases
  • Cellular and molecular mechanisms of bone remodeling

Background:

  • Bone remodeling is a continuous process of resorption and formation, crucial for skeletal integrity.
  • Dysregulation, particularly excess resorption, causes bone loss and fractures, as seen in osteoporosis.
  • Osteoblast and osteoclast differentiation and function are tightly regulated by various factors.

Purpose of the Study:

  • To investigate the role of a novel inhibitor of osteoblast differentiation, Ciz, in bone remodeling.
  • To determine the effect of Ciz deficiency on bone mass and skeletal characteristics.

Main Methods:

  • Utilized Ciz-deficient mouse models.
  • Analyzed bone mass and skeletal phenotypes in these mice.
  • Investigated the molecular mechanisms of Ciz action, including interference with bone morphogenic protein signaling.

Main Results:

  • Ciz was identified as an inhibitor of osteoblast differentiation.
  • Ciz deficiency led to a significant increase in bone mass in mice.
  • Ciz was shown to interfere with bone morphogenic protein signaling pathways.

Conclusions:

  • Ciz plays a critical role in regulating bone formation by inhibiting osteoblast differentiation.
  • Targeting Ciz may offer a novel therapeutic strategy for treating osteoporosis and other bone loss disorders.
  • Understanding Ciz's mechanism provides insights into controlling bone remodeling for therapeutic benefit.

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...